Human Cell Biology ELISA Kits 6
Human SPB (Pulmonary Surfactant Associated Protein B) ELISA Kit (HUES02325)
- SKU:
- HUES02325
- Product Type:
- ELISA Kit
- Size:
- 96 Assays
- Uniprot:
- P07988
- Sensitivity:
- 0.47ng/mL
- Range:
- 0.78-50ng/mL
- ELISA Type:
- Sandwich
- Reactivity:
- Human
- Sample Type:
- Serum, plasma and other biological fluids
- Research Area:
- Cell Biology
Description
Assay type: | Sandwich |
Format: | 96T |
Assay time: | 4.5h |
Reactivity: | Human |
Detection Method: | Colormetric |
Detection Range: | 0.78-50 ng/mL |
Sensitivity: | 0.47 ng/mL |
Sample Volume Required Per Well: | 100µL |
Sample Type: | Serum, plasma and other biological fluids |
Specificity: | This kit recognizes Human SPB in samples. No significant cross-reactivity or interference between Human SPB and analogues was observed. |
This ELISA kit uses Sandwich-ELISA as the method. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human SPB. Standards or samples are added to the appropriate micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human SPB and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well successively and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human SPB, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by adding Stop Solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human SPB. The concentration of Human SPB in samples can be calculated by comparing the OD of the samples to the standard curve.
UniProt Protein Function: | SFTPB: Pulmonary surfactant-associated proteins promote alveolar stability by lowering the surface tension at the air- liquid interface in the peripheral air spaces. SP-B increases the collapse pressure of palmitic acid to nearly 70 millinewtons per meter. Defects in SFTPB are the cause of pulmonary surfactant metabolism dysfunction type 1 (SMDP1); also called pulmonary alveolar proteinosis due to surfactant protein B deficiency. A rare lung disorder due to impaired surfactant homeostasis. It is characterized by alveolar filling with floccular material that stains positive using the periodic acid- Schiff method and is derived from surfactant phospholipids and protein components. Excessive lipoproteins accumulation in the alveoli results in severe respiratory distress. Genetic variations in SFTPB are a cause of susceptibility to respiratory distress syndrome in premature infants (RDS). RDS is a lung disease affecting usually premature newborn infants. It is characterized by deficient gas exchange, diffuse atelectasis, high-permeability lung edema and fibrin-rich alveolar deposits called 'hyaline membranes'. A variation Ile to Thr at position 131 influences the association between specific alleles of SFTPA1 and respiratory distress syndrome in premature infants. |
UniProt Protein Details: | Protein type:Secreted, signal peptide; Secreted Chromosomal Location of Human Ortholog: 2p12-p11. 2 Cellular Component: extracellular space; lysosome Biological Process: organ morphogenesis; sphingolipid metabolic process; respiratory gaseous exchange Disease: Surfactant Metabolism Dysfunction, Pulmonary, 1 |
NCBI Summary: | This gene encodes the pulmonary-associated surfactant protein B (SPB), an amphipathic surfactant protein essential for lung function and homeostasis after birth. Pulmonary surfactant is a surface-active lipoprotein complex composed of 90% lipids and 10% proteins which include plasma proteins and apolipoproteins SPA, SPB, SPC and SPD. The surfactant is secreted by the alveolar cells of the lung and maintains the stability of pulmonary tissue by reducing the surface tension of fluids that coat the lung. The SPB enhances the rate of spreading and increases the stability of surfactant monolayers in vitro. Multiple mutations in this gene have been identified, which cause pulmonary surfactant metabolism dysfunction type 1, also called pulmonary alveolar proteinosis due to surfactant protein B deficiency, and are associated with fatal respiratory distress in the neonatal period. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Feb 2010] |
UniProt Code: | P07988 |
NCBI GenInfo Identifier: | 288856299 |
NCBI Gene ID: | 6439 |
NCBI Accession: | NP_000533. 3 |
UniProt Secondary Accession: | P07988,Q96R04, |
UniProt Related Accession: | P07988 |
Molecular Weight: | 42,117 Da |
NCBI Full Name: | pulmonary surfactant-associated protein B |
NCBI Synonym Full Names: | surfactant protein B |
NCBI Official Symbol: | SFTPB |
NCBI Official Synonym Symbols: | SP-B; PSP-B; SFTB3; SFTP3; SMDP1 |
NCBI Protein Information: | pulmonary surfactant-associated protein B; 6 kDa protein; 18 kDa pulmonary-surfactant protein; pulmonary surfactant-associated proteolipid SPL(Phe) |
UniProt Protein Name: | Pulmonary surfactant-associated protein B |
UniProt Synonym Protein Names: | 18 kDa pulmonary-surfactant protein; 6 kDa protein; Pulmonary surfactant-associated proteolipid SPL(Phe) |
Protein Family: | Pulmonary surfactant-associated protein |
UniProt Gene Name: | SFTPB |
UniProt Entry Name: | PSPB_HUMAN |
As the OD values of the standard curve may vary according to the conditions of the actual assay performance (e. g. operator, pipetting technique, washing technique or temperature effects), the operator should establish a standard curve for each test. Typical standard curve and data is provided below for reference only.
Concentration (ng/mL) | O.D | Average | Corrected |
50 | 2.296 2.326 | 2.311 | 2.245 |
25 | 1.518 1.53 | 1.524 | 1.458 |
12.5 | 0.845 0.829 | 0.837 | 0.771 |
6.25 | 0.424 0.438 | 0.431 | 0.365 |
3.13 | 0.225 0.209 | 0.217 | 0.151 |
1.57 | 0.175 0.147 | 0.161 | 0.095 |
0.78 | 0.108 0.122 | 0.115 | 0.049 |
0 | 0.063 0.069 | 0.066 | -- |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Human SPB were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Human SPB were tested on 3 different plates, 20 replicates in each plate.
Intra-assay Precision | Inter-assay Precision | |||||
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 2.42 | 7.23 | 22.89 | 2.26 | 7.33 | 20.64 |
Standard deviation | 0.16 | 0.35 | 0.71 | 0.12 | 0.41 | 1.05 |
C V (%) | 6.61 | 4.84 | 3.10 | 5.31 | 5.59 | 5.09 |
Recovery
The recovery of Human SPB spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.
Sample Type | Range (%) | Average Recovery (%) |
Serum (n=5) | 94-105 | 99 |
EDTA plasma (n=5) | 88-99 | 94 |
Cell culture media (n=5) | 89-101 | 94 |
Linearity
Samples were spiked with high concentrations of Human SPB and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.
Serum (n=5) | EDTA plasma (n=5) | Cell culture media (n=5) | ||
1:2 | Range (%) | 88-102 | 96-107 | 87-100 |
Average (%) | 93 | 102 | 93 | |
1:4 | Range (%) | 91-107 | 81-93 | 89-102 |
Average (%) | 98 | 88 | 94 | |
1:8 | Range (%) | 90-101 | 83-93 | 84-98 |
Average (%) | 95 | 88 | 89 | |
1:16 | Range (%) | 86-98 | 82-95 | 84-95 |
Average (%) | 92 | 87 | 89 |
An unopened kit can be stored at 4°C for 1 month. If the kit is not used within 1 month, store the items separately according to the following conditions once the kit is received.
Item | Specifications | Storage |
Micro ELISA Plate(Dismountable) | 8 wells ×12 strips | -20°C, 6 months |
Reference Standard | 2 vials | |
Concentrated Biotinylated Detection Ab (100×) | 1 vial, 120 µL | |
Concentrated HRP Conjugate (100×) | 1 vial, 120 µL | -20°C(shading light), 6 months |
Reference Standard & Sample Diluent | 1 vial, 20 mL | 4°C, 6 months |
Biotinylated Detection Ab Diluent | 1 vial, 14 mL | |
HRP Conjugate Diluent | 1 vial, 14 mL | |
Concentrated Wash Buffer (25×) | 1 vial, 30 mL | |
Substrate Reagent | 1 vial, 10 mL | 4°C(shading light) |
Stop Solution | 1 vial, 10 mL | 4°C |
Plate Sealer | 5 pieces | |
Product Description | 1 copy | |
Certificate of Analysis | 1 copy |
- Set standard, test sample and control (zero) wells on the pre-coated plate and record theirpositions. It is recommended to measure each standard and sample in duplicate. Note: addall solutions to the bottom of the plate wells while avoiding contact with the well walls. Ensuresolutions do not foam when adding to the wells.
- Aliquot 100 µL of standard solutions into the standard wells.
- Add 100 µL of Sample / Standard dilution buffer into the control (zero) well.
- Add 100 µL of properly diluted sample (serum, plasma, tissue homogenates and otherbiological fluids) into test sample wells.
- Cover the plate with the sealer provided in the kit and incubate for 90 min at 37 °C.
- Aspirate the liquid from each well, do not wash. Immediately add 100 µL of BiotinylatedDetection Ab working solution to each well. Cover the plate with a plate seal and gently mix. Incubate for 1 hour at 37 °C.
- Aspirate or decant the solution from the plate and add 350 µL of wash buffer to each welland incubate for 1-2 minutes at room temperature. Aspirate the solution from each well andclap the plate on absorbent filter paper to dry. Repeat this process 3 times. Note: a microplatewasher can be used in this step and other wash steps.
- Add 100 µL of HRP Conjugate working solution to each well. Cover with a plate seal andincubate for 30 min at 37 °C.
- Aspirate or decant the solution from each well. Repeat the wash process for five times asconducted in step 7.
- Add 90 µL of Substrate Reagent to each well. Cover with a new plate seal and incubate forapproximately 15 min at 37 °C. Protect the plate from light. Note: the reaction time can beshortened or extended according to the actual color change, but not by more than 30min.
- Add 50 µL of Stop Solution to each well. Note: Adding the stop solution should be done inthe same order as the substrate solution.
- Determine the optical density (OD value) of each well immediately with a microplate readerset at 450 nm.